nodes	percent_of_prediction	percent_of_DWPC	metapath
Aceprometazine—HRH1—Monoamine GPCRs—ADRA1D—polycystic ovary syndrome	0.0357	0.0548	CbGpPWpGaD
Aceprometazine—HRH1—Monoamine GPCRs—ADRA1B—polycystic ovary syndrome	0.0347	0.0533	CbGpPWpGaD
Aceprometazine—Propericiazine—ADRA1B—polycystic ovary syndrome	0.0345	0.0988	CrCbGaD
Aceprometazine—HRH1—Amine ligand-binding receptors—ADRA1D—polycystic ovary syndrome	0.03	0.0461	CbGpPWpGaD
Aceprometazine—HRH1—Amine ligand-binding receptors—ADRA1B—polycystic ovary syndrome	0.0292	0.0448	CbGpPWpGaD
Aceprometazine—HRH1—Monoamine GPCRs—ADRA1A—polycystic ovary syndrome	0.0263	0.0404	CbGpPWpGaD
Aceprometazine—HRH1—Monoamine GPCRs—ADRB3—polycystic ovary syndrome	0.0253	0.0389	CbGpPWpGaD
Aceprometazine—Acepromazine—ADRA1B—polycystic ovary syndrome	0.0221	0.0635	CrCbGaD
Aceprometazine—HRH1—Amine ligand-binding receptors—ADRA1A—polycystic ovary syndrome	0.0221	0.034	CbGpPWpGaD
Aceprometazine—Thioproperazine—ADRA1B—polycystic ovary syndrome	0.0216	0.0621	CrCbGaD
Aceprometazine—HRH1—Amine ligand-binding receptors—ADRB3—polycystic ovary syndrome	0.0213	0.0327	CbGpPWpGaD
Aceprometazine—Propiomazine—ADRA1D—polycystic ovary syndrome	0.0207	0.0595	CrCbGaD
Aceprometazine—Methotrimeprazine—ADRA1D—polycystic ovary syndrome	0.0177	0.0509	CrCbGaD
Aceprometazine—Propiomazine—ADRA1B—polycystic ovary syndrome	0.0177	0.0508	CrCbGaD
Aceprometazine—Thioridazine—ADRA1B—polycystic ovary syndrome	0.0159	0.0455	CrCbGaD
Aceprometazine—Trimipramine—ADRA1B—polycystic ovary syndrome	0.0155	0.0444	CrCbGaD
Aceprometazine—Promazine—ADRA1D—polycystic ovary syndrome	0.0154	0.0441	CrCbGaD
Aceprometazine—Methotrimeprazine—ADRA1B—polycystic ovary syndrome	0.0151	0.0434	CrCbGaD
Aceprometazine—Acepromazine—ADRA1A—polycystic ovary syndrome	0.0149	0.0427	CrCbGaD
Aceprometazine—Thioproperazine—ADRA1A—polycystic ovary syndrome	0.0146	0.0418	CrCbGaD
Aceprometazine—HRH1—Monoamine GPCRs—ADRB2—polycystic ovary syndrome	0.0137	0.021	CbGpPWpGaD
Aceprometazine—Promazine—ADRA1B—polycystic ovary syndrome	0.0131	0.0376	CrCbGaD
Aceprometazine—Propiomazine—ADRA1A—polycystic ovary syndrome	0.0119	0.0342	CrCbGaD
Aceprometazine—Levomethadyl Acetate—CYP19A1—polycystic ovary syndrome	0.0117	0.0335	CrCbGaD
Aceprometazine—Chlorpromazine—ADRA1B—polycystic ovary syndrome	0.0115	0.0331	CrCbGaD
Aceprometazine—HRH1—Amine ligand-binding receptors—ADRB2—polycystic ovary syndrome	0.0115	0.0176	CbGpPWpGaD
Aceprometazine—Thioridazine—ADRA1A—polycystic ovary syndrome	0.0107	0.0306	CrCbGaD
Aceprometazine—Trimipramine—ADRA1A—polycystic ovary syndrome	0.0104	0.0299	CrCbGaD
Aceprometazine—Methotrimeprazine—ADRA1A—polycystic ovary syndrome	0.0102	0.0292	CrCbGaD
Aceprometazine—Promethazine—ADRA1A—polycystic ovary syndrome	0.01	0.0288	CrCbGaD
Aceprometazine—Trifluoperazine—ADRA1A—polycystic ovary syndrome	0.0099	0.0284	CrCbGaD
Aceprometazine—HRH1—G alpha (q) signalling events—PTAFR—polycystic ovary syndrome	0.00918	0.0141	CbGpPWpGaD
Aceprometazine—HRH1—G alpha (q) signalling events—ADRA1D—polycystic ovary syndrome	0.00891	0.0137	CbGpPWpGaD
Aceprometazine—Promazine—ADRA1A—polycystic ovary syndrome	0.00883	0.0253	CrCbGaD
Aceprometazine—HRH1—G alpha (q) signalling events—ADRA1B—polycystic ovary syndrome	0.00867	0.0133	CbGpPWpGaD
Aceprometazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PTAFR—polycystic ovary syndrome	0.00821	0.0126	CbGpPWpGaD
Aceprometazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRA1D—polycystic ovary syndrome	0.00797	0.0122	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—NPB—polycystic ovary syndrome	0.00779	0.012	CbGpPWpGaD
Aceprometazine—Chlorpromazine—ADRA1A—polycystic ovary syndrome	0.00777	0.0223	CrCbGaD
Aceprometazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRA1B—polycystic ovary syndrome	0.00775	0.0119	CbGpPWpGaD
Aceprometazine—HRH1—GPCRs, Class A Rhodopsin-like—PTGER3—polycystic ovary syndrome	0.00758	0.0116	CbGpPWpGaD
Aceprometazine—HRH1—GPCRs, Class A Rhodopsin-like—LHCGR—polycystic ovary syndrome	0.00758	0.0116	CbGpPWpGaD
Aceprometazine—HRH1—GPCRs, Class A Rhodopsin-like—PTAFR—polycystic ovary syndrome	0.00709	0.0109	CbGpPWpGaD
Aceprometazine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA1D—polycystic ovary syndrome	0.00689	0.0106	CbGpPWpGaD
Aceprometazine—Methadone—CYP19A1—polycystic ovary syndrome	0.00685	0.0196	CrCbGaD
Aceprometazine—HRH1—IL-4 Signaling Pathway—IRS2—polycystic ovary syndrome	0.00685	0.0105	CbGpPWpGaD
Aceprometazine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA1B—polycystic ovary syndrome	0.0067	0.0103	CbGpPWpGaD
Aceprometazine—HRH1—G alpha (q) signalling events—ADRA1A—polycystic ovary syndrome	0.00657	0.0101	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—PTGER3—polycystic ovary syndrome	0.0065	0.00998	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—LHCGR—polycystic ovary syndrome	0.0065	0.00998	CbGpPWpGaD
Aceprometazine—HRH1—G alpha (q) signalling events—GNRH1—polycystic ovary syndrome	0.00611	0.00938	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—PTAFR—polycystic ovary syndrome	0.00608	0.00933	CbGpPWpGaD
Aceprometazine—HRH1—IL-4 Signaling Pathway—IRS1—polycystic ovary syndrome	0.00598	0.00918	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—NPB—polycystic ovary syndrome	0.00593	0.0091	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA1D—polycystic ovary syndrome	0.0059	0.00906	CbGpPWpGaD
Aceprometazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRA1A—polycystic ovary syndrome	0.00587	0.00902	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.00574	0.00881	CbGpPWpGaD
Aceprometazine—HRH1—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.00555	0.00852	CbGpPWpGaD
Aceprometazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—polycystic ovary syndrome	0.00546	0.00838	CbGpPWpGaD
Aceprometazine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA1A—polycystic ovary syndrome	0.00508	0.0078	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.00495	0.0076	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.00495	0.0076	CbGpPWpGaD
Aceprometazine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.00489	0.0075	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.00476	0.0073	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.00463	0.00711	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.00449	0.0069	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.00437	0.00671	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA1A—polycystic ovary syndrome	0.00435	0.00668	CbGpPWpGaD
Aceprometazine—HRH1—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.00432	0.00663	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.00419	0.00643	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.00414	0.00635	CbGpPWpGaD
Aceprometazine—HRH1—G alpha (q) signalling events—GHRL—polycystic ovary syndrome	0.00412	0.00633	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.00404	0.00621	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.0037	0.00568	CbGpPWpGaD
Aceprometazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—polycystic ovary syndrome	0.00369	0.00566	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.00362	0.00556	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.00335	0.00514	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—ADRA1A—polycystic ovary syndrome	0.00331	0.00509	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.00319	0.0049	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—LHB—polycystic ovary syndrome	0.00315	0.00484	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.00308	0.00473	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—NPB—polycystic ovary syndrome	0.00304	0.00467	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.00303	0.00465	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00297	0.00455	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00297	0.00455	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—SCT—polycystic ovary syndrome	0.00295	0.00453	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.00282	0.00432	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.0028	0.00429	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.0028	0.00429	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.00275	0.00422	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.00273	0.00419	CbGpPWpGaD
Aceprometazine—HRH1—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.00264	0.00405	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.00262	0.00402	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.00254	0.0039	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.00254	0.0039	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.00254	0.0039	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00247	0.00379	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.00238	0.00365	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.00231	0.00354	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00226	0.00347	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.00225	0.00345	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.00224	0.00344	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.00208	0.00319	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00206	0.00316	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—FSHR—polycystic ovary syndrome	0.00205	0.00314	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—PDE3B—polycystic ovary syndrome	0.00204	0.00313	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—ADRA1A—polycystic ovary syndrome	0.00187	0.00287	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—FSHR—polycystic ovary syndrome	0.00186	0.00285	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.0018	0.00277	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—NPB—polycystic ovary syndrome	0.0018	0.00276	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00178	0.00273	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00174	0.00267	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.00172	0.00264	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.0017	0.00261	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.00167	0.00256	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.00164	0.00251	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00163	0.0025	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.00162	0.00248	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.0016	0.00245	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00159	0.00244	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.00158	0.00243	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.00152	0.00233	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.0015	0.0023	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.0015	0.0023	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.00145	0.00222	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.00141	0.00217	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.0014	0.00215	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00136	0.00209	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00132	0.00203	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.00129	0.00198	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.00121	0.00185	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.00118	0.0018	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.0011	0.00169	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.00107	0.00165	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.00107	0.00164	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.00103	0.00158	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.001	0.00154	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—FST—polycystic ovary syndrome	0.000979	0.0015	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000973	0.00149	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000967	0.00148	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000955	0.00147	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000934	0.00143	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000904	0.00139	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000902	0.00139	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000895	0.00137	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000884	0.00136	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000854	0.00131	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000839	0.00129	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000832	0.00128	CbGpPWpGaD
Aceprometazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000828	0.00127	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000819	0.00126	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000777	0.00119	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000766	0.00118	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000733	0.00112	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000696	0.00107	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000685	0.00105	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000678	0.00104	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000631	0.000968	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000631	0.000968	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000607	0.000933	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000602	0.000924	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000587	0.000901	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000584	0.000897	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000555	0.000852	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000552	0.000847	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—PRL—polycystic ovary syndrome	0.00055	0.000845	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.00053	0.000814	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000522	0.000801	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000484	0.000743	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000461	0.000708	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000453	0.000695	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000388	0.000595	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—LEP—polycystic ovary syndrome	0.000379	0.000582	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000338	0.00052	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—POMC—polycystic ovary syndrome	0.000326	0.0005	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—INS—polycystic ovary syndrome	0.000324	0.000498	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000313	0.000481	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000313	0.000481	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000298	0.000457	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—IL6—polycystic ovary syndrome	0.00024	0.000368	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000205	0.000314	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—IL6—polycystic ovary syndrome	0.000142	0.000217	CbGpPWpGaD
